Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 3 of 3

TitlePrioritisation programmeDecisionDecision date
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]None selectedAwaiting decision
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]None selectedNot selected
Image-guided high intensity focused ultrasound to treat breast cancerNone selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All